A

Apnimed

27 employees

Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Medical Device
Health Care
Medical
sleep medicine and Obstructive Sleep Apnea

Date founded

2017

Funding rounds raised

Total raised

$80M

from 6 investors over 6 rounds

A

Apnimed raised $80M on December 23, 2022

Investors: Sectoral Asset Management and Tao Capital Partners

A

Apnimed raised $63M on May 4, 2022

Investors: Sectoral Asset Management and Tao Capital Partners

A

Apnimed raised $25M on March 25, 2021

Investors: Morningside Venture Capital 晨兴资本 and Tao Capital Partners

FAQ